Premium
Cancer patients should be considered as a high risk priority target in the coronavirus disease 2019 vaccination process
Author(s) -
Souadka Amine,
Habbat Hajar,
Majbar Mohammed Anass,
Benkabbou Amine,
Amrani Laila,
Ghannam Abdelilah,
El Ahmadi Brahim,
Belkhadir Zakaria Houssaïn,
Mohsine Raouf
Publication year - 2021
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.26508
Subject(s) - medicine , pandemic , vaccination , cancer , disease , intensive care medicine , curfew , clinical trial , immune system , lung cancer , covid-19 , immunology , infectious disease (medical specialty)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom